Search Results - "Fang, Jiequn"
-
1
MiR-204-3p Inhibited the Proliferation of Bladder Cancer Cells via Modulating Lactate Dehydrogenase-Mediated Glycolysis
Published in Frontiers in oncology (29-11-2019)“…MicroRNAs (miRNAs) are endogenous non-coding RNAs that negatively regulate the expression of downstream targeted mRNAs. Increasing evidence has suggested that…”
Get full text
Journal Article -
2
Safety and Activity of Programmed Cell Death 1 Versus Programmed Cell Death Ligand 1 Inhibitors for Platinum-Resistant Urothelial Cancer: A Meta-Analysis of Published Clinical Trials
Published in Frontiers in oncology (01-04-2021)“…Programmed death 1/ligand 1 (PD-1/L1) inhibitors have acceptable antitumor activity in patients with platinum-resistant urothelial cancer (UC). However, the…”
Get full text
Journal Article -
3
Establishing a Urine-Based Biomarker Assay for Prostate Cancer Risk Stratification
Published in Frontiers in cell and developmental biology (10-12-2020)“…One of the major features of prostate cancer (PCa) is its heterogeneity, which often leads to uncertainty in cancer diagnostics and unnecessary biopsies as…”
Get full text
Journal Article -
4
Prognostic role of neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in prostate cancer: A meta-analysis of results from multivariate analysis
Published in International journal of surgery (London, England) (01-12-2018)“…The prognostic role of neutrophil to lymphocyte ratio (NLR) and platelet to lymphocyte ratio (PLR) in patients with prostate cancer (PCa) remains inconsistent…”
Get full text
Journal Article -
5
Can American Joint Committee on Cancer prognostic groups be individualized in patients undergoing surgery for Stage IV invasive upper tract Urothelial Carcinoma?
Published in Journal of Cancer (01-01-2021)“…We explored whether the modified American Joint Committee on Cancer tumor-node-metastasis prognostic stage group IV can be individualized in a large…”
Get full text
Journal Article